Genesee Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $239K | Sell |
5,160
-381
| -7% | -$17.6K | 0.11% | 107 |
|
|
2025
Q1 | $338K | Buy |
5,541
+340
| +7% | +$20.7K | 0.17% | 93 |
|
|
2024
Q4 | $294K | Buy |
5,201
+60
| +1% | +$3.39K | 0.14% | 103 |
|
|
2024
Q3 | $266K | Buy |
5,141
+7
| +0.1% | +$362 | 0.13% | 102 |
|
|
2024
Q2 | $213K | Buy |
5,134
+7
| +0.1% | +$291 | 0.1% | 114 |
|
|
2024
Q1 | $278K | Buy |
5,127
+56
| +1% | +$3.04K | 0.15% | 92 |
|
|
2023
Q4 | $260K | Buy |
+5,071
| New | +$260K | 0.16% | 87 |
|